Publication

Not the number but the location of lymph nodes matters for recurrence rate and disease-free survival in patients with differentiated thyroid cancer

de Meer, S. G. A., Dauwan, M., de Keizer, B., Valk, G. D., Borel Rinkes, I. H. M. & Vriens, M. R., Jun-2012, In : World Journal of Surgery. 36, 6, p. 1262-1267 6 p.

Research output: Contribution to journalArticleAcademicpeer-review

APA

de Meer, S. G. A., Dauwan, M., de Keizer, B., Valk, G. D., Borel Rinkes, I. H. M., & Vriens, M. R. (2012). Not the number but the location of lymph nodes matters for recurrence rate and disease-free survival in patients with differentiated thyroid cancer. World Journal of Surgery, 36(6), 1262-1267. https://doi.org/10.1007/s00268-012-1427-1

Author

de Meer, S G A ; Dauwan, M ; de Keizer, B ; Valk, G D ; Borel Rinkes, I H M ; Vriens, M R. / Not the number but the location of lymph nodes matters for recurrence rate and disease-free survival in patients with differentiated thyroid cancer. In: World Journal of Surgery. 2012 ; Vol. 36, No. 6. pp. 1262-1267.

Harvard

de Meer, SGA, Dauwan, M, de Keizer, B, Valk, GD, Borel Rinkes, IHM & Vriens, MR 2012, 'Not the number but the location of lymph nodes matters for recurrence rate and disease-free survival in patients with differentiated thyroid cancer', World Journal of Surgery, vol. 36, no. 6, pp. 1262-1267. https://doi.org/10.1007/s00268-012-1427-1

Standard

Not the number but the location of lymph nodes matters for recurrence rate and disease-free survival in patients with differentiated thyroid cancer. / de Meer, S G A; Dauwan, M; de Keizer, B; Valk, G D; Borel Rinkes, I H M; Vriens, M R.

In: World Journal of Surgery, Vol. 36, No. 6, 06.2012, p. 1262-1267.

Research output: Contribution to journalArticleAcademicpeer-review

Vancouver

de Meer SGA, Dauwan M, de Keizer B, Valk GD, Borel Rinkes IHM, Vriens MR. Not the number but the location of lymph nodes matters for recurrence rate and disease-free survival in patients with differentiated thyroid cancer. World Journal of Surgery. 2012 Jun;36(6):1262-1267. https://doi.org/10.1007/s00268-012-1427-1


BibTeX

@article{b6541e2ed6ee4e3cb53d64ac1c45729c,
title = "Not the number but the location of lymph nodes matters for recurrence rate and disease-free survival in patients with differentiated thyroid cancer",
abstract = "BACKGROUND: Several Japanese studies have focused on identifying prognostic factors in patients with positive lymph nodes to predict recurrence rate and disease-free survival (DFS). However, different treatment protocol is followed in Japan compared with the European and American approach. This study was designed to investigate whether the number and/or location of lymph nodes predicts prognosis in patients with DTC treated with total thyroidectomy, lymph node dissection, and postoperative radioactive iodine ablation.METHODS: All 402 patients who were treated at the Department of Nuclear Medicine between 1998 and 2010 for DTC were reviewed. Patients were treated with (near) total thyroidectomy, lymph node dissection on indication, and postoperative I-131 ablation. Median follow-up was 49 (range, 10-240) months. Outcome measures were recurrence rate, disease-free survival, and mean time to recurrence.RESULTS: Ninety-seven patients had proven lymph node metastases. Recurrence rate was significantly higher in patients with positive lymph nodes in the lateral compartment vs. patients with lymph node metastasis in the central compartment (60 vs. 30{\%}, p = 0.007). Disease-free survival and mean time to recurrence also were significantly shorter (30 vs. 52 months, p = 0.035 and 7 vs. 44 months, p = 0.004, respectively). The number of lymph nodes and extranodal growth were not significantly associated with the outcome measures used.CONCLUSIONS: The location of positive lymph nodes was significantly correlated with the risk of recurrence and a shorter DFS. Hence, the TNM criteria are useful in subdividing patients based on risk of recurrence and DFS.",
keywords = "Ablation Techniques/methods, Adenocarcinoma, Follicular, Adult, Aged, Carcinoma, Carcinoma, Papillary, Combined Modality Therapy, Disease-Free Survival, Female, Follow-Up Studies, Humans, Iodine Radioisotopes/therapeutic use, Kaplan-Meier Estimate, Lymphatic Metastasis, Male, Middle Aged, Neck Dissection, Neoplasm Recurrence, Local, Neoplasm Staging, Retrospective Studies, Thyroid Cancer, Papillary, Thyroid Neoplasms/mortality, Thyroidectomy, Treatment Outcome",
author = "{de Meer}, {S G A} and M Dauwan and {de Keizer}, B and Valk, {G D} and {Borel Rinkes}, {I H M} and Vriens, {M R}",
year = "2012",
month = "6",
doi = "10.1007/s00268-012-1427-1",
language = "English",
volume = "36",
pages = "1262--1267",
journal = "World Journal of Surgery",
issn = "0364-2313",
publisher = "SPRINGER",
number = "6",

}

RIS

TY - JOUR

T1 - Not the number but the location of lymph nodes matters for recurrence rate and disease-free survival in patients with differentiated thyroid cancer

AU - de Meer, S G A

AU - Dauwan, M

AU - de Keizer, B

AU - Valk, G D

AU - Borel Rinkes, I H M

AU - Vriens, M R

PY - 2012/6

Y1 - 2012/6

N2 - BACKGROUND: Several Japanese studies have focused on identifying prognostic factors in patients with positive lymph nodes to predict recurrence rate and disease-free survival (DFS). However, different treatment protocol is followed in Japan compared with the European and American approach. This study was designed to investigate whether the number and/or location of lymph nodes predicts prognosis in patients with DTC treated with total thyroidectomy, lymph node dissection, and postoperative radioactive iodine ablation.METHODS: All 402 patients who were treated at the Department of Nuclear Medicine between 1998 and 2010 for DTC were reviewed. Patients were treated with (near) total thyroidectomy, lymph node dissection on indication, and postoperative I-131 ablation. Median follow-up was 49 (range, 10-240) months. Outcome measures were recurrence rate, disease-free survival, and mean time to recurrence.RESULTS: Ninety-seven patients had proven lymph node metastases. Recurrence rate was significantly higher in patients with positive lymph nodes in the lateral compartment vs. patients with lymph node metastasis in the central compartment (60 vs. 30%, p = 0.007). Disease-free survival and mean time to recurrence also were significantly shorter (30 vs. 52 months, p = 0.035 and 7 vs. 44 months, p = 0.004, respectively). The number of lymph nodes and extranodal growth were not significantly associated with the outcome measures used.CONCLUSIONS: The location of positive lymph nodes was significantly correlated with the risk of recurrence and a shorter DFS. Hence, the TNM criteria are useful in subdividing patients based on risk of recurrence and DFS.

AB - BACKGROUND: Several Japanese studies have focused on identifying prognostic factors in patients with positive lymph nodes to predict recurrence rate and disease-free survival (DFS). However, different treatment protocol is followed in Japan compared with the European and American approach. This study was designed to investigate whether the number and/or location of lymph nodes predicts prognosis in patients with DTC treated with total thyroidectomy, lymph node dissection, and postoperative radioactive iodine ablation.METHODS: All 402 patients who were treated at the Department of Nuclear Medicine between 1998 and 2010 for DTC were reviewed. Patients were treated with (near) total thyroidectomy, lymph node dissection on indication, and postoperative I-131 ablation. Median follow-up was 49 (range, 10-240) months. Outcome measures were recurrence rate, disease-free survival, and mean time to recurrence.RESULTS: Ninety-seven patients had proven lymph node metastases. Recurrence rate was significantly higher in patients with positive lymph nodes in the lateral compartment vs. patients with lymph node metastasis in the central compartment (60 vs. 30%, p = 0.007). Disease-free survival and mean time to recurrence also were significantly shorter (30 vs. 52 months, p = 0.035 and 7 vs. 44 months, p = 0.004, respectively). The number of lymph nodes and extranodal growth were not significantly associated with the outcome measures used.CONCLUSIONS: The location of positive lymph nodes was significantly correlated with the risk of recurrence and a shorter DFS. Hence, the TNM criteria are useful in subdividing patients based on risk of recurrence and DFS.

KW - Ablation Techniques/methods

KW - Adenocarcinoma, Follicular

KW - Adult

KW - Aged

KW - Carcinoma

KW - Carcinoma, Papillary

KW - Combined Modality Therapy

KW - Disease-Free Survival

KW - Female

KW - Follow-Up Studies

KW - Humans

KW - Iodine Radioisotopes/therapeutic use

KW - Kaplan-Meier Estimate

KW - Lymphatic Metastasis

KW - Male

KW - Middle Aged

KW - Neck Dissection

KW - Neoplasm Recurrence, Local

KW - Neoplasm Staging

KW - Retrospective Studies

KW - Thyroid Cancer, Papillary

KW - Thyroid Neoplasms/mortality

KW - Thyroidectomy

KW - Treatment Outcome

U2 - 10.1007/s00268-012-1427-1

DO - 10.1007/s00268-012-1427-1

M3 - Article

VL - 36

SP - 1262

EP - 1267

JO - World Journal of Surgery

JF - World Journal of Surgery

SN - 0364-2313

IS - 6

ER -

ID: 79049533